World-first type 1 diabetes risk screening study in adults opens for recruitment

A world-first research programme led by the University of Bristol that will identify adults at high risk of developing type 1 diabetes opens for recruitment.

Enveric Biosciences Announces Two Poster Presentations at the Canadian Chemistry Conference and Exhibition (CSC 2023) | Psychedelic Invest

Enveric Biosciences, Inc. (NASDAQ: ENVB), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, today

June 7, 2023

Diet and sedentary behavior influence adiposity in obese children, study finds

The relationship between physical activity, sedentary behavior, and diet quality

November 8, 2023

Caregiver warmth during childhood protects cardiovascular health later in life

Previous research has established that childhood experience with abuse, neglect, and substance use in the home can worsen a person’s heart health throughout their life.

January 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.